105-107
FINALCharlotte
Hornets
21-66|L10: 1-9
Philadelphia
76ers
26-61|L10: 1-9
-
//
Sports
- All Players
- Seasons
Eastern Conference
Western Conference
More
Sign in
Sign in and connect Sleeper to unlock personalized fantasy insights.
Charlotte Hornets
Philadelphia 76ers
| # | Team | W-L | Pct | GB |
|---|---|---|---|---|
| 1 | 65-22 | 0.747 | — | |
| 2 |
| Opponent | Date | Result |
|---|---|---|
| 11/9 | W 103-83 | |
| 11/7 |
| 64-22 |
| 0.744 |
| 0.5 |
| 3 | 55-32 | 0.632 | 10.0 |
| 4 | 52-34 | 0.605 | 12.5 |
| 5 | 50-37 | 0.575 | 15.0 |
| 6 | 47-40 | 0.540 | 18.0 |
| 7 | 42-43 | 0.494 | 22.0 |
| 8 | 42-45 | 0.483 | 23.0 |
| 9 | 41-45 | 0.477 | 23.5 |
| 10 | 41-46 | 0.471 | 24.0 |
| 11 | 33-54 | 0.379 | 32.0 |
| 12 | 27-59 | 0.314 | 37.5 |
| 13 | 26-61 | 0.299 | 39.0 |
| 14 | 21-66 | 0.241 | 44.0 |
| 15 | 20-67 | 0.230 | 45.0 |
| 11/5 | L 93-114 |
| 11/2 | L 103-113 |
| 11/1 | L 109-124 |
| Opponent | Date | Result |
|---|---|---|
| 11/9 | L 106-116 | |
| 11/6 | L 98-110 | |
| 11/5 | L 116-118 | |
| 11/2 | L 107-124 | |
| 10/30 | L 95-105 |
| Player | PointsPPG | FG% | 3P% | FT% |
|---|---|---|---|---|
| 24.4 | 39.7% | 34.6% | 74.1% | |
| 20.5 | 41.3% | 38.2% | 69.0% | |
| 19.7 | 42.5% | 31.2% | 75.5% |
| Player | PointsPPG | FG% | 3P% | FT% |
|---|---|---|---|---|
| 25.2 |
| 32.0% |
| 85.7% |
| 23.8 | 42.5% | 33.2% | 83.9% |
| 21.9 | 44.7% | 35.4% | 68.8% |
| Category | PHI Offense | CHA Defense | Advantage |
|---|---|---|---|
Offensive RatingPoints scored per 100 possessions | #2090.4 ORtg | #23114.0 DRtg | PHI |
Turnover RateLower offensive turnovers vs defensive forced turnovers | #910.8% | #2312.6% | CHA |
3P% vs AllowedPerimeter efficiency vs perimeter defense | #2834.0% | #1035.5% | CHA |
| Category | PHI Defense | CHA Offense | Advantage |
|---|---|---|---|
Offensive RatingPoints allowed per 100 possessions | #26115.7 DRtg | #3084.1 ORtg | CHA |
Turnover RateDefensive takeaways vs offensive giveaways | #315.3% | #2812.1% | PHI |
3P% vs AllowedPerimeter defense vs perimeter shooting | #2937.7% | #2534.2% | PHI |
